Key points are not available for this paper at this time.
Health digital twins (HDTs) are virtual representations of real individuals that can be used to simulate human physiology, disease, and drug effects. HDTs can be used to improve drug discovery and development by providing a data-driven approach to inform target selection, drug delivery, and design of clinical trials. HDTs also offer new applications into precision therapies and clinical decision making. The deployment of HDTs at scale could bring a precision approach to public health monitoring and intervention. Next steps include challenges such as addressing socioeconomic barriers and ensuring the representativeness of the technology based on the training and validation data sets. Governance and regulation of HDT technology are still in the early stages.
Building similarity graph...
Analyzing shared references across papers
Loading...
Kaushik P. Venkatesh
Brigham and Women's Hospital
Gabriel Brito
Harvard University
Maged N. Kamel Boulos
University of Lisbon
The Annual Review of Pharmacology and Toxicology
Harvard University
University of Lisbon
Building similarity graph...
Analyzing shared references across papers
Loading...
Venkatesh et al. (Thu,) studied this question.
synapsesocial.com/papers/69d87f49d2f7327e70ae34a7 — DOI: https://doi.org/10.1146/annurev-pharmtox-022123-022046